Annual CAPEX
N/A
31 December 2023
Summary:
Spyre Therapeutics annual capital expenditures is not available.SYRE CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CAPEX
N/A
30 September 2024
Summary:
Spyre Therapeutics quarterly capital expenditures is not available.SYRE Quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CAPEX
N/A
30 September 2024
Summary:
Spyre Therapeutics TTM capital expenditures is not available.SYRE TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SYRE CAPEX Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | - | - |
| 3 y3 years | - | - | - |
| 5 y5 years | - | - | - |
SYRE CAPEX High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | ||||||
| 5 y | 5 years | ||||||
| alltime | all time |
Spyre Therapeutics CAPEX History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2022 | $38.00 K(-93.4%) | - | - |
| Dec 2022 | - | $0.00(-100.0%) | $38.00 K(0.0%) |
| Sept 2022 | - | $1000.00(>+9900.0%) | $38.00 K(-70.8%) |
| June 2022 | - | $0.00(-100.0%) | $130.00 K(-18.8%) |
| Mar 2022 | - | $37.00 K(>+9900.0%) | $160.00 K(-72.1%) |
| Dec 2021 | $573.00 K(-86.6%) | $0.00(-100.0%) | $573.00 K(-63.6%) |
| Sept 2021 | - | $93.00 K(+210.0%) | $1.57 M(-23.1%) |
| June 2021 | - | $30.00 K(-93.3%) | $2.05 M(-38.8%) |
| Mar 2021 | - | $450.00 K(-55.0%) | $3.34 M(-21.9%) |
| Dec 2020 | $4.28 M(+186.9%) | $1.00 M(+76.7%) | $4.28 M(-3.9%) |
| Sept 2020 | - | $566.00 K(-57.3%) | $4.45 M(+10.5%) |
| June 2020 | - | $1.32 M(-4.6%) | $4.03 M(+45.9%) |
| Mar 2020 | - | $1.39 M(+18.3%) | $2.76 M(+85.2%) |
| Dec 2019 | $1.49 M | $1.17 M(+721.0%) | $1.49 M(+186.4%) |
| Sept 2019 | - | $143.00 K(+150.9%) | $521.00 K(+8.8%) |
| June 2019 | - | $57.00 K(-51.7%) | $479.00 K(+4.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2019 | - | $118.00 K(-41.9%) | $457.00 K(+8.3%) |
| Dec 2018 | $422.00 K(-31.8%) | $203.00 K(+101.0%) | $422.00 K(+2.9%) |
| Sept 2018 | - | $101.00 K(+188.6%) | $410.00 K(-2.4%) |
| June 2018 | - | $35.00 K(-57.8%) | $420.00 K(-2.6%) |
| Mar 2018 | - | $83.00 K(-56.5%) | $431.00 K(-30.4%) |
| Dec 2017 | $619.00 K(+192.0%) | $191.00 K(+72.1%) | $619.00 K(+12.8%) |
| Sept 2017 | - | $111.00 K(+141.3%) | $549.00 K(+25.3%) |
| June 2017 | - | $46.00 K(-83.0%) | $438.00 K(-8.9%) |
| Mar 2017 | - | $271.00 K(+124.0%) | $481.00 K(+126.9%) |
| Dec 2016 | $212.00 K(+1.9%) | $121.00 K(>+9900.0%) | $212.00 K(+61.8%) |
| Sept 2016 | - | $0.00(-100.0%) | $131.00 K(-50.6%) |
| June 2016 | - | $89.00 K(+4350.0%) | $265.00 K(+32.5%) |
| Mar 2016 | - | $2000.00(-95.0%) | $200.00 K(+1.0%) |
| Dec 2015 | $208.00 K | $40.00 K(-70.1%) | $198.00 K(+25.3%) |
| Sept 2015 | - | $134.00 K(+458.3%) | $158.00 K(+558.3%) |
| June 2015 | - | $24.00 K | $24.00 K |
FAQ
- What is the all time high annual CAPEX for Spyre Therapeutics?
- What is the all time high quarterly CAPEX for Spyre Therapeutics?
- What is the all time high TTM CAPEX for Spyre Therapeutics?
What is the all time high annual CAPEX for Spyre Therapeutics?
Spyre Therapeutics all-time high annual capital expenditures is $4.28 M
What is the all time high quarterly CAPEX for Spyre Therapeutics?
Spyre Therapeutics all-time high quarterly capital expenditures is $1.39 M
What is the all time high TTM CAPEX for Spyre Therapeutics?
Spyre Therapeutics all-time high TTM capital expenditures is $4.45 M